When Ozempic And Wegovy Fail To Work- Why GLP-1 Drugs Aren’t The Magic Bullet For Everyone
Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.
Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.
While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:
1. Genetic and Hormonal Variability
Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.
2. Underlying Medical Conditions
Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.
3. Unrealistic Expectations
Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.
For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.
For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.
When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:
For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.
While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.
Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.
It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.
For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.
Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.
This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.
While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.
The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.
Credits: Canva
Kerala has recently seen a sharp increase in hepatitis A cases, drawing national attention after media reports revealed more than 31,000 infections and 82 deaths recorded by the end of December 2025, according to NDTV. The World Health Organization (WHO) states that Hepatitis A leads to mild or severe illness in around 1.4 million people each year, while nearly 113 million individuals get infected without showing symptoms. Globally, the disease claimed an estimated 7,134 lives in 2016. With numbers climbing in Kerala, here is a closer look at what hepatitis A is, how it spreads, and the precautions people should take.
Kerala has reported its highest number of hepatitis A cases so far, raising renewed worries around drinking water quality, sanitation standards, and disease monitoring. As per The Hindu, the state logged 31,536 confirmed and suspected cases along with 82 deaths as of December 30, 2025. Health specialists say the outbreak did not happen overnight. It reflects long-standing pressure on early detection systems, sanitation facilities, and public water supply networks. Since Hepatitis A tends to be more severe in older age groups, the growing number of infections among adolescents and adults has become a major concern.
Hepatitis A is a viral infection of the liver caused by the hepatitis A virus (HAV). It spreads mainly through contaminated food or water, or close personal contact with an infected person. The infection can cause liver inflammation, jaundice, extreme tiredness, and stomach pain. In most cases, it is a short-term illness that clears on its own without specific treatment, though severe cases can occur. Unlike hepatitis B or C, hepatitis A does not lead to long-term liver damage. The WHO notes that vaccination remains the most reliable way to stay protected.
Symptoms of hepatitis A usually show up a few weeks after exposure to the virus, though some people never develop noticeable signs. According to the Cleveland Clinic, those who do may experience:
These symptoms are often mild and disappear within weeks. In some cases, however, the illness can be intense and last for several months.
Kerala has faced several hepatitis A outbreaks in recent years, but the current rise is notable for its scale and severity. Reports cited by The Hindu link the spread to contaminated groundwater, poor sanitation, and unhygienic surroundings, particularly in crowded localities. Investigations suggest that inadequate environmental hygiene and unsafe water sources have played a key role in allowing the virus to spread more widely.
Yes, prevention is possible. The Cleveland Clinic states that vaccination against hepatitis A is the simplest and most effective safeguard. Doctors recommend the vaccine for children older than 12 months and for adults who:
Basic hygiene also goes a long way in preventing infection. Regular handwashing and careful food handling can reduce the risk significantly. Outbreaks often worsen when simple safety habits are ignored. Small daily choices can protect your liver. Drinking boiled or bottled water, avoiding food from unhygienic sources, and peeling fruits at home can help lower the risk.
If someone in the household is infected, cleanliness becomes even more important. Surfaces should be disinfected, food prepared carefully, and personal items not shared. Safe sexual practices also matter, as the virus can spread through oral-anal contact. On a broader level, preventing future outbreaks requires more than short-term fixes. Improving water quality, repairing sewage systems, and strengthening public health surveillance are essential to stop the cycle from repeating.
Credits: iStock
What looks like a simple biological process of being born, living, and then dying, may have another layer that not many know. Between life and death, your cells could be conscious, or what scientists call "third state of life".
Human body is made of 30 trillion human cells and microbes. They all function together to maintain life. Research show that in the near death experience, there may be a "third state of life". What does it mean? It means that cells are able to continue and in fact, reorganize even after an organism dies. Does it mean that human consciousness also does the same even when we are not aware?
There are reports of survivors of near-death experiences who see vivid dream. These are tunnel vision of light, or a feeling of calm. But, what happens to those who do not come back? Could their cells be undergoing a change and also be reorganized in ways we do not understand?
This concept gained momentum with the emergence of xenobots, which is AI-created multicellular creatures that exhibit autonomy outside their initial biological purpose. These mall biological robots are constructed from frog embryo cells, which, when introduced into new environments, spontaneously reconfigure and assume new functions. For instance, instead of employing their hair-like cilia to move mucus as they would in a living frog, xenobots redirect these structures for mobility.
This phenomenon proves that cells are capable of being reassembled into new shapes and functions even after the death of an organism. Researchers opine that this postmortem cellular plasticity is not exclusive to xenobots. Human cells, or "anthrobots," also display such actions, proving the ability for posthumous cellular reorganization and transformation.
At the heart of the debate is a provocative question: can cells be conscious? Physician and evolutionary biologist William Miller explores this idea in The Sentient Cell, where he argues that cells possess a basic form of awareness. His Cellular Basis of Consciousness (CBC) hypothesis suggests that cells don’t simply follow genetic instructions on autopilot. Instead, they can make decisions, adapt to changing conditions, and act to preserve themselves, traits that resemble a primitive kind of consciousness.
This challenges the traditional view of genes as the sole masters of biology. Miller proposes that genes function more like tools, while intelligent cellular behavior drives cooperation, mutual support, and problem-solving. In this view, life evolves not just through “survival of the fittest,” but through collaboration and adaptability.
Historically, death has been defined as irreversible loss of organismal biological activity. Yet such medical procedures as organ donation illustrate that some organs, tissues, and cells maintain their functional properties even after death—sometimes for hours, days, or weeks under optimal circumstances.
A number of factors will decide whether cells survive after death. Environmental parameters, the state of metabolism, and methods of preservation are all important. Human white blood cells, for instance, can last between 60 and 86 hours from the time of death, while those of mice skeletal muscle can regenerate two weeks after death. Some fibroblast cells in sheep and goats have even been grown up to a month following the organism's death.
In addition, researchers have discovered that certain human lung cells are capable of self-assembling into small multicellular structures that can move and heal themselves. These "anthrobots" exhibit a capacity to explore their environment and repair injured neurons, abilities that contradict traditional assumptions about cellular behavior following death.
Credits: Canva
If flu symptoms such as fever, chills, coughing, a sore throat or a pounding headache start to creep in, many people assume the best option is to stay in bed and let it pass.
But even if you have managed the flu on your own in the past, this time it may be worth calling your doctor. That’s because antiviral flu medicines, including Tamiflu, can sometimes make a real difference.
Certain prescription drugs can shorten how long the flu lasts and lower the risk of serious complications, but timing is critical. Here’s how to work out whether flu antivirals could help you or someone close to you.
Flu antivirals are prescription medicines designed to help the body fight off the influenza virus. “They work by stopping the flu virus from multiplying and spreading through the body. Influenza is the virus that causes the flu,” explained Deon Pilkington, PharmD, a clinical pharmacy coordinator as per Banner Health.
These medications do not cure the flu, but they may:
All flu antivirals require a prescription and are most effective when started within the first one to two days after symptoms appear. That’s why reaching out to a healthcare provider early can matter.
Antibiotics should not be used to treat the flu. “Because influenza is caused by a virus, antibiotics won’t help,” said Mallory Yan, PharmD, a pharmacist with Banner Health.
Not everyone who gets the flu needs prescription treatment. “These medications are generally reserved for people who have confirmed flu and are at higher risk for complications,” Dr. Pilkington said.
You should contact a doctor promptly if you or someone you care for falls into one of these categories:
Even healthy individuals may be prescribed antivirals if they live with someone at high risk. Limiting the spread of flu in households where complications could be serious is important.
If you are at higher risk, it’s best to contact your doctor as soon as flu symptoms begin. Starting treatment within 48 hours offers the greatest benefit.
Warning signs may include:
If you test positive for flu or feel seriously unwell, do not delay. Beginning antiviral treatment within the first two days gives you the best chance of recovering faster and avoiding complications.
If you’re wondering, “Do I need Tamiflu?” remember that flu antivirals are most helpful when taken early, ideally within the first day or two after symptoms begin. Acting quickly can change how the illness unfolds.
© 2024 Bennett, Coleman & Company Limited